ClinConnect ClinConnect Logo
Search / Trial NCT05746533

An Evaluation of Hip Preservation Outcomes

Launched by YALE UNIVERSITY · Feb 16, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "An Evaluation of Hip Preservation Outcomes," is studying the results of surgeries aimed at preserving the hip joint, specifically for conditions like femoroacetabular impingement (FAI). FAI occurs when the bones of the hip joint do not fit together perfectly, which can cause pain and limit movement. The trial is currently looking for participants who are considering surgery to treat this condition. If you are between the ages of 43 and 82, and you or your guardian can understand and agree to participate, you might be eligible to join.

If you decide to participate, you will be part of a study that examines how well different types of hip surgeries work. The study will track your recovery and outcomes after the surgery. However, there are some important things to note: if you have had certain hip problems in the past, like specific fractures or previous surgeries, you may not qualify for this study. This trial is open to all genders, and the goal is to gather information that can help improve treatment for hip conditions in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Candidates for surgical intervention of the hip
  • Participant and/or guardian has given informed consent and assent as applicable.
  • Exclusion Criteria:
  • Documented history of pre-existing hip conditions (SCFE, LCPD, acetabular fractures)
  • Has language or cognitive barriers preventing understanding of study and consent and assent documents
  • Prior revision surgeries
  • Patients from the trauma/emergency department
  • Individuals with Unusable x-rays

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

New Haven, Connecticut, United States

Patients applied

0 patients applied

Trial Officials

Andrew Jimenez, MD

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials